Nuvalent Inc vs Atlassian Corporation PLC — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Atlassian Corporation PLC trades at $90.58 (market cap $23.67B). The key difference: Atlassian Corporation PLC is far larger — about 2.4× Nuvalent Inc's market cap, and Nuvalent Inc is trading nearer its 52-week high, Atlassian Corporation PLC nearer its low. Which is the better fit depends on your goals.
| NUVL | TEAM | |
|---|---|---|
Market Cap | $9.81B | $23.67B |
Sector | Technology | Technology |
52-Week High | $123.96 | $203.00 |
52-Week Low | $72.16 | $57.15 |
Enterprise Value | $8.52B | $23.78B |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →